These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12617091)

  • 41. Can you recognize and respond to von Willebrand disease?
    Paper R
    Nursing; 2003 Jul; 33(7):54-6. PubMed ID: 12851503
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of desmopressin as a hemostatic agent: a concise review.
    Franchini M
    Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
    Hardy JF; Bélisle S
    Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
    [No Abstract]   [Full Text] [Related]  

  • 44. The clinical application of bioflavonoids in otolaryngology.
    GOLDMAN HB
    Eye Ear Nose Throat Mon; 1956 Apr; 35(4):246-9. PubMed ID: 13305600
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.
    Pasi KJ; Collins PW; Keeling DM; Brown SA; Cumming AM; Dolan GC; Hay CR; Hill FG; Laffan M; Peake IR
    Haemophilia; 2004 May; 10(3):218-31. PubMed ID: 15086319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menorrhagia due to abnormalities of the platelet function: evaluation of two young patients.
    Aydinok Y; Egemen A; Balkan C
    Pediatr Int; 2007 Feb; 49(1):106-8. PubMed ID: 17250517
    [No Abstract]   [Full Text] [Related]  

  • 47. Current antifibrinolytic therapy for coronary artery revascularization.
    Trudell J; McMurdy N
    AANA J; 2008 Apr; 76(2):121-4. PubMed ID: 18478817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Local and systemic hemostasis in surgery].
    Bechstein WO; Strey C
    Chirurg; 2007 Feb; 78(2):95-6, 98-100. PubMed ID: 17237955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic and therapeutic measures in congenital blood coagulation disorders].
    Eggert JH
    Dtsch Zahnarztl Z; 1982 Nov; 37(11):877-84. PubMed ID: 6816566
    [No Abstract]   [Full Text] [Related]  

  • 50. [Von Willebrand disease--from biochemistry to clinical practice].
    Sveinsdottir SV; Hillarp A; Astermark J; Svensson PJ; Berntorp E
    Lakartidningen; 2010 Aug 25-31; 107(34):1923-7. PubMed ID: 20960954
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention and treatment of bleeding by pro-hemostatic treatment strategies.
    Levi M; Vink R; de Jonge E
    Wien Med Wochenschr; 2003; 153(19-20):421-5. PubMed ID: 14648922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrin sealant: update on clinical studies.
    Murphy WG; Milne AA; Ruckley CV; Kubba AK; Palmer KR
    Transfus Sci; 1996 Sep; 17(3):341-2. PubMed ID: 10163539
    [No Abstract]   [Full Text] [Related]  

  • 53. More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.
    Koscielny J; Kiesewetter H; von Tempelhoff GF
    J Thromb Haemost; 2006 Jun; 4(6):1426-7; discussion 1428-34. PubMed ID: 16706998
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
    Martínez Rodríguez E; Mato M; Otero J; Ferri JR; Gonzálvez A; Torres LM
    Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):195-7. PubMed ID: 16671265
    [No Abstract]   [Full Text] [Related]  

  • 55. Procoagulant therapeutics in liver disease: a critique and clinical rationale.
    Shah NL; Intagliata NM; Northup PG; Argo CK; Caldwell SH
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):675-82. PubMed ID: 25023035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemorrhage control in the battlefield: role of new hemostatic agents.
    Alam HB; Burris D; DaCorta JA; Rhee P
    Mil Med; 2005 Jan; 170(1):63-9. PubMed ID: 15724857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood conservation in cardiac surgery.
    Anderson L
    J Perioper Pract; 2010 Dec; 20(12):436-9. PubMed ID: 21265402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Apropos of emergency management of hemophiliac patients with suspected hemorrhage].
    Sultan Y
    Presse Med; 1999 Mar; 28(11):595-6. PubMed ID: 10214385
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol.
    Glauber M; Szefner J; Senni M; Gamba A; Mamprin F; Fiocchi R; Somaschini M; Ferrazzi P
    Int J Artif Organs; 1995 Oct; 18(10):649-55. PubMed ID: 8647598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.